COVID-19 Treatment in Medan, Indonesia: A Case Report

How to Cite:Fadinie W. COVID-19 Treatment in Medan, Indonesia: A Case Report. J Cell Mol Anesth. 2021;6(2):e150290. doi: https://doi.org/10.22037/jcma.v6i2.33927

Abstract

In the past decades, two known zoonotic coronaviruses, SARS-CoV and MERS-CoV, have been reported to damage the respiratory tract and cause severe outbreaks. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a newly discovered coronavirus, which was first discovered in Wuhan, China in December 20191. Coronaviruses are enveloped, positive single-strandedlarge RNA viruses that infect humans, but also a widerange of animals. Coronaviruses were first described in 1966 by Tyrell and Bynoe, who cultivated the viruses from patients with common colds2 SARS-CoV-2, which belongs to a unique clade of the Sarbecovirus subgenus of the Orthocoronavirinae subfamily, was identified as the pathogen of Coronavirus disease 2019 (COVID-19) in January 2020 3. A majority (67-85%) of critically ill patients admitted in intensive care units with confirmed infection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) developed the acute respiratory distress syndrome (ARDS)4 The maximum incubation period is assumed to be up to 14 days, whereas the median time from onset of symptoms to intensive care unit (ICU) admission is around 10 days. Recently, WHO reported that the time between symptom onset and death ranged from about 2 weeks to 8 weeks5. The severity of patient?s symptoms was categorized as mild, severe, or critical. Mild included non-pneumonia and mild pneumonia cases. Severe was characterized by dyspnea, respiratory frequency ?30/minute, blood oxygen saturation ?93%, PaO2/FiO2ratio <300, and/or lung infiltrates >50% within 24?48hours. Critical cases were those that exhibited respiratory failure, septic shock, and/or multiple organ dysfunction/failure6,7

Keywords

References

1.
References are in the PDF file of the article.

The Current Clinically Relevant Findings on COVID-19 Pandemic

Joseph V. Pergolizzi Jr.,

Peter Magnusson,

Jo Ann LeQuang,

Frank Breve,

Antonella Paladini,

Martina Rekatsina

,et al.

Pergolizzi Jr. JV, Magnusson P, LeQuang JA, Breve F, Paladini A, et al. The Current Clinically Relevant Findings on COVID-19 Pandemic. Anesth Pain Med. 2020;10(2):e103819. doi: https://doi.org/10.5812/aapm.103819

11

Jul

2020

SARS-CoV, MERS-CoV, SARS-CoV-2 Comparison of Three Emerging Coronaviruses

Agnieszka Zeidler,

Tomasz M. Karpinski

Zeidler A, Karpinski TM. SARS-CoV, MERS-CoV, SARS-CoV-2 Comparison of Three Emerging Coronaviruses. Jundishapur J Microbiol. 2020;13(6):e103744. doi: https://doi.org/10.5812/jjm.103744

31

Jul

2020

Approaches for the Treatment of SARS-CoV-2 Infection: A Pharmacologic View and Literature Review

Hajar Mohammadi Barzelighi,

Bahram Daraei,

Farzaneh Dastan

Mohammadi Barzelighi H, Daraei B, Dastan F. Approaches for the Treatment of SARS-CoV-2 Infection: A Pharmacologic View and Literature Review. Iran J Pharm Res. 2020;19(3):e124629. doi: https://doi.org/10.22037/ijpr.2020.113821.14506

7

May

2020

COVID-19: Features, clinical course and concerns

Parvaneh Darabi,

Mehrdad Bagherpour kalo,

Kosar Ali,

Saeed Safari,

Mahmoud Yousefifard,

Mostafa Hosseini

Darabi P, Bagherpour kalo M, Ali K, Safari S, Yousefifard M, et al. COVID-19: Features, clinical course and concerns. J Cell Mol Anesth. 2020;5(2):e149613. doi: https://doi.org/10.22037/jcma.v5i2.29885

9

Apr

2020

Insights into the SARS-CoV2 Outbreak; the Great Global Challenge: A Mini Review

Dr Behzad Pourhossain,

Ali Dabbagh,

Maryam Fazeli

Pourhossain DB, Dabbagh A, Fazeli M. Insights into the SARS-CoV2 Outbreak; the Great Global Challenge: A Mini Review. J Cell Mol Anesth. 2020;5(1):e149605. doi: https://doi.org/10.22037/jcma.v5i1.29718

Import into EndNote Import into BibTex

Crossmark

Checking

Share on

Comments

Number of Comments:0

Cited by

Scopus by DOI: 1
Last Update: 3 weeks ago
Scopus by Title: 1
Last Update: 3 weeks ago
Scopus by Title (Ref): 1
Last Update: 3 weeks ago
CrossRef: 0
Last Update: 1 day ago

Metrics

Licensing and reuse information

Ordering Reprints

Articles are published under the Creative Commons license stated on each article. No permission or royalty fee is required for uses permitted by that license. CCC handles optional bulk and customized reprint orders. Any quotation covers production and delivery services only, not copyright permission. > Request Reprints from CCC

Search Relations

Author(s):

Wulan Fadinie:[PubMed][Scholar]

Outlines

COVID-19 Treatment in Medan, Indonesia: A Case Report

Abstract

References

Similar Articles

The Current Clinically Relevant Findings on COVID-19 Pandemic

SARS-CoV, MERS-CoV, SARS-CoV-2 Comparison of Three Emerging Coronaviruses

Approaches for the Treatment of SARS-CoV-2 Infection: A Pharmacologic View and Literature Review

COVID-19: Features, clinical course and concerns

Insights into the SARS-CoV2 Outbreak; the Great Global Challenge: A Mini Review

Crossmark

Checking

Last Update: 3 weeks ago

Last Update: 3 weeks ago

Last Update: 3 weeks ago

Last Update: 1 day ago